Ontology highlight
ABSTRACT:
SUBMITTER: Nagashima R
PROVIDER: S-EPMC9892566 | biostudies-literature | 2023 Feb
REPOSITORIES: biostudies-literature
Nagashima Ryuichi R Ishikawa Hiroki H Kuno Yoshihiro Y Kohda Chikara C Iyoda Masayuki M
Scientific reports 20230201 1
Hypoxia-inducible factor-prolyl hydroxylase (HIF-PHD) inhibitors are therapeutic agents for renal anemia that work through HIF2-mediated upregulation of erythropoietin (EPO) and have also been reported to suppress renal fibrosis. Group 2 innate lymphoid cells (ILC2s) have been proven to be involved in the pathogenesis of fibrosis in various organs, including the kidney. However, the relationship between the HIF pathway, renal fibrosis, and kidney ILC2s remains unclear. In the present study, we f ...[more]